Inhibition of 11β-HSD1 enzymatic action is perceived as a potential target for the treatment of metabolic syndromes like cardiovascular diseases, obesity, and diabetes. In an attempt to formulate potential organophosphorus compounds against 11β-HSD1 enzyme inhibition, we report novel 6-bromo-3-(6-methyl-2-pyridyl)-2-alkyl/arylamino-3,4-dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-ones 22a–22n as good in vitro inhibitors of HEK 293 cell lines. The in vivo acute and sub-acute investigations sustain them as good antidiabetic compounds. The computational docking studies performed on them also supported the binding mode of compounds 22a and 22h with 11β-HSD1 protein. The blood glucose level lowering effect of the target compounds 22a–22n screened on the streptozotocin-induced diabetic rats revealed that the target compounds are potential by antidiabetic when compared to the potency of standard glibenclamide drug. In addition, the calculated QSAR parameters, predicted ADMET properties, evaluated bioactivity properties and toxicity risk studies authorize drug like properties to the synthesized compounds.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diacare 27:S5–S10
Armarego WLF, Perrin DD (1997) Purification of laboratory chemicals, 4th edn. Butterworth, Heinemann
Balakrishna A, Kishore KC, Reddy MVN, Reddy R, Nayak SK, Raghavan SC, Reddy CS (2010) Synthesis, characterization and evaluation of cytotoxicity of new aminophosphonic acid diesters in human leukemia cells. Lett Drug Des Discov 7:250–259
Balakrishna A, Reddy MVN, Rao PV, Kumar MA, Kumar BS, Nayak SK, Reddy CS (2011) Synthesis and bio-activity evaluation of tetraphenyl(phenylamino) methylene bisphosphonates as antioxidant agents and as potent inhibitors of osteoclasts in vitro. Eur J Med Chem 46:1798–1802
Calderwood D, Arnold LD, Mazdiyasni H, Hirst G, Deng BB, Twigger HL, Munschauer R (2005) 4-Aminopyrrolopyrimidines as kinase inhibitors, European Patent, EP1114052B1, 16 Nov 2005
Caterina B, Henrietta D, Rainer EM, Ulrike OS, Hans R, Christoph U (2010) Novel phenyl amide or pyridyl amide derivatives. US Patent 20,100,105,906A1, 29 Apr 2010
Díaz HM, Molina RV, Andrade RO, Coutiño DD, Franco JLM, Webstere SP, Binnie M, Soto SE, Barajas MI, Rivera IL, Vázquez GN (2008) Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. Bioorg Med Chem Lett 18:2871–2877
Duan H, Ning M, Chen X, Zou Q, Zhang L, Feng Y, Zhang L, Leng Y, Shen J (2012) Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists. J Med Chem 55:10475–10489
Frazier CP, Bugarin A, Engelking JR, Alaniz JR (2012) Copper-catalyzed aerobic oxidation of N-substituted hydroxylamines: efficient and practical access to nitroso compounds. Org Lett 14:3620–3623
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association, diabetes and cardiovascular care. J Am Heart Assoc 100:1134–1146
Hasanvanda F, Hoseinzadeha A, Zolgharnein J, Amani S (2010) Synthesis and characterization of two acetato-bridged dinuclear copper(II) complexes with 4-bromo-2-((4 or 6-methylpyridin-2-ylimino)methyl)phenol as ligand. J Coord Chem 63:346–352
Hoon C, Hsin HT (2002) Thiazolidinediones as a novel class of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors. Arch Biochem Biophys 405:247–251
Ichihara Y, Fujimura R, Tsuneki H, Wada T, Okamoto K, Gouda H, Hirono S, Sugimoto K, Matsuya Y, Sasaoka T, Toyooka N (2013) Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with Inhibitory effects on SH2 domain-containing inositol 5′-phosphatase 2 (SHIP2). Eur J Med Chem 62:649–660
Jurgen S, Silks LA, Ryszard M (2005) Piperazine-based nucleic acid analogs, US Patent, US006841675B1, 11 Jan 2005
Kemp W (1991) Organic spectroscopy, 3rd edn. Palgrave, New York
Kiran YB, Gunasekar D, Reddy CD, Reddy CS, Tran K, Le T, Berlin KD, Srinivasan S, Devi MC (2005) Synthesis and bioactivity of some new N-(substituted aryl/alkyl/cyclohexyl)-N′-[2,3-dihydro-2-oxido-3-(3′-chloro-4′-fluorophenyl)-1H-(1,3,2) benzoxaza-phosphorin 2-yl] ureas. Pest Manag Sci 61:1016–1023
Kiran YB, Reddy CD, Gunasekar D, Reddy CS, Leon A, Barbosa LCA (2008) Synthesis and anticancer activity of new class of bisphosphonates/phosphanamidates. Eur J Med Chem 43:885–892
Kumar MA, Kumar KS, Reddy CD, Raju CN, Reddy CS, Krishna PH (2009) Synthesis and antimicrobial activity of 2-(aminoacid ester)-3-(6-methyl-2-pyridyl)-3,4-dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-thiones. S Afr J Chem 62:26–29
Magid AFA, Carson KG, Harris BD, Maryanoff CA, Shah RD (1996) Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures1. J Org Chem 61:3849–3862
MOE (2011) (Molecular Operating Environment 2011.10) Chemical Computing Group Inc., Montreal, QC, Canada
Oprea TI, Matter H (2004) Integrating virtual screening in lead discovery. Curr Opin Chem Biol 8:349–358
Phan HT, Nguyen LM, Niesor E, Guyon GY, Bentzen CL (1993) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them. US patent 5,424,303, 26 Feb 1993
Quin LD (2000) A guide to organophosphorus chemistry. Wiley, New York
Rao VK, Reddy SS, Krishna BS, Reddy CS, Reddy NP, Reddy TCM, Raju CN, Ghosh SK (2011) Design, synthesis and anti-colon cancer activity evaluation of phosphorylated derivatives of lamivudine (3TC). Lett Drug Des Discov 8:59–64
Rao PV, Madhavi K, Naidu MD, Gan SH (2013) Rhinacanthus nasutus improves liver glycogen, carbohydrate, total protein and liver markers in streptozotocin induced diabetic rats, Evidence based Complementary and alternative medicine 2013(1–7):102901. doi:10.1155/2013/102901
Reddy MV, Balakrishna A, Reddy CS (2010) Synthesis, spectral characterization and bioassay of 3,3′-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines]. Eur J Med Chem 45:1828–1832
Roglic G, Unwin N (2010) Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 87:15–19
Sarabu R, Tilley J (2005) Recent advances in therapeutic approaches to type 2 diabetes. Ann Rep Med Chem 40:167–181
Seckl JR, Walker BR (2001) 11β-Hydroxysteroid dehydrogenase Type 1: a tissue specific amplifier of glucocorticoid action. Endocrinology 142:1371–1376
Shaw J, Sicree R, Zimmet P (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
Thomas LC (1974) Interpretation of the infrared spectra of organophosphorus compounds. Hyden & Son Ltd, London
Webster SP, Ward P, Binnie M, Craigie E, McConnell KMM, Sooy K, Vinter A, Seckl JR, Walker BR (2007) Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitors. Bioorg Med Chem Lett 17:2838–2843
Wu Y, Tai H, Cho H (2010) Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors. Bioorg Med Chem 18:1428–1433
We thank University Grants Commission (UGC), New Delhi, INDIA for providing financial support through UGC-BSR-RFSMS (Research Fellowship In Sciences For Meritorious Students) Fellowship (F.4-1/2011, BSR-RFSMS-BSK) and for providing financial assistance through the Major Research Project (F. No.: 42-281/2013 (SR), Dated: 12-03-2013). We also thank Dr. V. Koteswara Rao, Post doctoral Fellow, Kansas University, Kansas, USA for providing MOE software for QSAR and Molecular docking studies.
Conflict of interest
We state that none of the authors have any conflict of interest in the context of this communication.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (PDF 1811 kb) Supporting Information Additional Supporting Information may be found in the online version of this article containing Structure Activity Relationship correlation studies as Fig. (3), binding mode parameters of ligands with the 11β-HSD1 binding site in Table 10 and spectra of compound 22e
About this article
Cite this article
Balam, S.K., Krishnammagari, S.K., Soora Harinath, J. et al. Synthesis of N-(3-picolyl)-based 1,3,2λ5-benzoxazaphosphinamides as potential 11β-HSD1 enzyme inhibitors. Med Chem Res 24, 1119–1135 (2015). https://doi.org/10.1007/s00044-014-1194-7
- 11β-HSD1 inhibition
- ADMET properties
- In vivo antidiabetic activity
- In vitro HEK 293 cell inhibition
- QSAR studies